Residual disease kinetics among patients treated with first-line fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab: The GLOW study
Talha Munir, Carsten Niemann,Carol Moreno,Carolyn Owen,George Follows,Ohad Benjamini,Ann Janssens,Mark-David Levin,Anders Osterborg,Tadeusz Robak,Martin Simkovic,Sergey Voloshin,Vladimir Vorobyev,Munci Yagci, Loic Ysebaert,Keqin Qi, Qianyaya Qi,Lori Parisi,Srimathi Srinivasan,Natasha Schuier,Kurt Baeten, Angela Howes,Donne Bennett Caces,Arnon Kater BRITISH JOURNAL OF HAEMATOLOGY(2023)
AI 理解论文
溯源树
样例